The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: August 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

4. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer

  • 1. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
  • 2. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
  • 3. Single-cell spatial immune landscapes of primary and metastatic brain tumours
  • 4. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
  • 5. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
  • 6. Tissue memory relies on stem cell priming in distal undamaged areas
  • 7. Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
  • 8. Distant antimetastatic effect of enterotropic colon cancer-derived α4β7+CD8+ T cells
  • 9. Tumour extracellular vesicles and particles induce liver metabolic dysfunction
  • 10. A neutrophil response linked to tumor control in immunotherapy
  • 11.
Previous
Next

Lin, J., Wang, S., Coy, S. et al. Cell. 186(2): 363-381 (2023).
doi: 10.1016/j.cell.2022.12.028.

**Summary, future impact and graphical abstract by Alexandra Boitor**

Summary of the findings

Solid tumour cancers are heterogeneous in nature and encompass immune and stromal cells in addition to tumour cells. Lin, Wang, Coy et al. used multiplexed imaging coupled with 3D tissue reconstruction, spatial statistics and machine learning in an attempt to characterise tumour composition and morphological traits of diagnostic and prognostic importance in colorectal cancer.

The authors show that the molecular state and tissue morphology change gradually within the tumour and are characterised by gradient changes in the expression of various markers such as E-cadherin, PCNA, cytokeratin 20, cytokeratin 18, and epigenetic markers such as histone acetylation and trimethylation.

The authors also show that common histopathological features, often seen as individual structures are in fact part of larger, interconnected 3D structures. For instance, 3D reconstruction of the tissue suggests that tumour buds in the invasive margin of the tumour, adjacent to normal mucosa may in fact be cross-sections through the distal tips of larger, 3D fibrillar structures characterised by a graded EMT-like transition. Similarly, the authors observed that often secondary lymph organs and tertiary lymphoid structures are interconnected forming 3D networks that can be found along the invasive front of the tumour, inside the tumour or in deeper layers.

Substantial differences in immune activity have been noticed at the invasive front of the tumour. The invasive margin adjacent to normal mucosa presents the greatest density of immune cells, although it shows strong immunosuppressive characteristics (rich in T reg and PDL1+ cells). PD1+ – PDL1+ cell interactions are enriched in proximity to the tumour buds in the stroma. The “mucinous invasive margin” is characterised by the least infiltration of immune cells, whilst the “pushing invasive margin” presented few PDL1+ cells in comparison to the invasive margin adjacent to normal mucosa but was enriched in T regs. Tumour buds are characterised by low cell proliferation whilst cell proliferation in the deep invasive margin is high. Differences in active signalling pathways have also been noticed.

The panels showing examples of molecular and morphologic gradients, 3D structures and tumour-immune interactions have been replicated from Lin, Jia-Ren, et al. “Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer.” Cell 186.2 (2023): 363-381.

Future impact

By analysing the tumour microenvironment concomitantly from morphological and signalling perspectives, this study enriches the current understanding of tumour biology in general and tumour heterogeneity in particular. The authors challenge the definition and perception of some commonly used morphological features with prognostic value and highlight the gradual changes in molecular states and morphological features within the tumour.

Read more in Cell

4. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer

  • 1. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
  • 2. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
  • 3. Single-cell spatial immune landscapes of primary and metastatic brain tumours
  • 4. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
  • 5. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
  • 6. Tissue memory relies on stem cell priming in distal undamaged areas
  • 7. Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
  • 8. Distant antimetastatic effect of enterotropic colon cancer-derived α4β7+CD8+ T cells
  • 9. Tumour extracellular vesicles and particles induce liver metabolic dysfunction
  • 10. A neutrophil response linked to tumor control in immunotherapy
  • 11.
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026

Erik Sahai, Principal Group Leader and Deputy Research Director at the Francis Crick Institute, travelled to Nanchang, China, this month to deliver an EACR keynote talk...

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

August 17, 2026

Nazha Ghaleb (who goes by Nana) has been an EACR member for over two years, and an EACR Ambassador for much of that time. A molecular...

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

August 12, 2026

EACR member Amel Aziba has now completed her EACR-Molecular Oncology Editorial Fellowship, funding that is awarded to enable a talented cancer researcher to gain knowledge and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Spotlight on the Portuguese Association for Cancer Research (ASPIC)
Community

Spotlight on the Portuguese Association for Cancer Research (ASPIC)

August 27, 2026
EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference
Community

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR